Process for the preparation of amorphous form of (4S)-2-{8-Fluoro-2-[4-(3- methoxyphenyl) piperazin-1-yl]-3-[2-methoxy-5­(trifluoromethyl)phenyl]-3,4-dihydro quinazolin-4-yl} acetic acid

Inventor(s)

• MSN Laboratories Private Limited, R&D Center; Hyderabad, India; Srinivasan Thirumalai Rajan; Revu Satyanarayana and Challa Suresh.Follow

Abstract

The present disclosure relates to process for the preparation of amorphous form of (4S)-2-{8-Fluoro-2-[4-(3-methoxyphenyl) piperazin-1-yl]-3-[2-methoxy-5­(trifluoromethyl)phenyl]-3,4-dihydro quinazolin-4-yl} acetic acid of formula-1

Formula-1.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.

Recommended Citation

MSN Laboratories Private Limited, R&D Center; Hyderabad, India; Srinivasan Thirumalai Rajan; Revu Satyanarayana and Challa Suresh., "Process for the preparation of amorphous form of (4S)-2-{8-Fluoro-2-[4-(3- methoxyphenyl) piperazin-1-yl]-3-[2-methoxy-5­(trifluoromethyl)phenyl]-3,4-dihydro quinazolin-4-yl} acetic acid", Technical Disclosure Commons, ()
https://www.tdcommons.org/dpubs_series/10525